Recursion Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
12 Jul 23 | SellUS$8,147 | Christopher Gibson | Individual | 568 | US$14.34 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 13,604 | 0.00579% |
General Public | 1,955,878 | 0.832% |
Individual Insiders | 11,876,629 | 5.05% |
Sovereign Wealth Funds | 12,985,927 | 5.52% |
VC/PE Firms | 13,619,224 | 5.79% |
Institutions | 194,662,759 | 82.8% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 22.9%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
24,179,504 | US$178.9m | -1.51% | 0.08% | |||
23,076,052 | US$170.8m | 11.7% | 1.17% | |||
15,665,210 | US$115.9m | 1.02% | no data | |||
13,619,224 | US$100.8m | 0% | 57.01% | |||
12,985,927 | US$96.1m | 0% | 0.18% | |||
12,393,872 | US$91.7m | 4.53% | no data | |||
12,151,646 | US$89.9m | 3.36% | no data | |||
10,896,398 | US$80.6m | 1.95% | 0.01% | |||
10,405,668 | US$77.0m | 0% | 7.0% | |||
9,203,780 | US$68.1m | 161% | 0.03% | |||
8,451,758 | US$62.5m | 0% | 12.82% | |||
7,706,363 | US$57.0m | 0% | 18.99% | |||
7,228,696 | US$53.5m | -1.68% | no data | |||
7,062,869 | US$52.3m | 0% | no data | |||
6,004,722 | US$44.4m | 0% | 41.28% | |||
3,591,730 | US$26.6m | 0% | no data | |||
3,531,964 | US$26.1m | -19.2% | no data | |||
3,325,985 | US$24.6m | 5.97% | no data | |||
3,154,691 | US$23.3m | -0.83% | no data | |||
2,273,964 | US$16.8m | -2.62% | 0.5% | |||
2,137,110 | US$15.8m | 153% | no data | |||
2,094,980 | US$15.5m | 214% | no data | |||
1,875,077 | US$13.9m | 142% | 0.46% | |||
1,644,281 | US$12.2m | 1.13% | 0.01% | |||
1,483,304 | US$11.0m | 979% | 0.02% |